N/A N=3 Spinal Cord Stimulation in Spinal Muscular Atrophy
Spinal Muscular Atrophy Type 3 · Spinal Muscular Atrophy Type 4
Primary: Muscle Weakness — 2; 3 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=254 Trevisio Post-Approval Study
PFO - Patent Foramen Ovale · ASD - Atrial Septal Defect · VSD - Muscular Ventricular Septal Defect
Primary: Effectiveness Endpoint: Rate of Technical Success — 247; 3 Participants — p=0.0044
N/A N=32 Comparison of Non-invasive Respiratory Monitoring System (RMS) to Capnography for Respiratory Rate (RR)
Respiratory Monitoring
Primary: Respiratory Rate Accuracy Compared Between Experimental and Reference Devices — .63 Breath Per Minute
N/A N=90 Mindfulness, Mental Fatigue, Inhibitory Control and Endurance Performance in Athletes
Mental Fatigue
Primary: Inhibitory Control: Reaction Time — 461.01; 448.68; 444.35; 465.88 millisecond
N/A N=135 Investigation of Mohs Surgical Margins Using Two Photon Microscopy
Basal Cell Carcinoma
Primary: Agreement Between Frozen Sections and Two Photon Fluorescence Microscopy on Mohs Margins — 72.7; 96.8 Percentage
N/A N=158 Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome
Chronic Pain
Primary: Clinical Pain Severity - 50% Reduction Responders vs Nonresponders — -83; 0 percentage of change
Phase 1 N=140 Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections
Uncomplicated Urinary Tract Infections · Urinary Tract Infections
Primary: Number of Participants With Microbiological Response at the Test of Cure (ToC) Visit — 10; 10; 1; 18 Participants
Phase 4 N=100 Dexamethasone vs Ondansetron After Cesarean Delivery
Nausea and Vomiting, Postoperative · Cesarean Section Complications
Primary: Medications Received — 0.23; 0.40 Medications
N/A N=64 Cognitive Rehabilitation in Post-COVID-19 Syndrome
Post-COVID-19 Syndrome
Primary: Recruitment Rate — 65 Participants
N/A N=20 Evaluation of a Program to Enhance Ophthalmic Compliance in Children and Adolescents With Special Needs
Visual Rehabilitation · Visual Impairment, Autism Spectrum Disorder, Developmental Disabilities, Intellectual Disability, Behavioral Symptoms
Primary: Visual Function Battery for Children With Special Needs (VFB-CSN) — 45.00; 48.21 score — p=0.008
N/A N=42 Adaptation and Implementation of a Cherokee-based Participatory Research Project to Reduce CVD Risk
Blood Pressure
Primary: Blood Pressure — 126.7; 127.7; 87.20; 88.15 mmHg — p=.91
N/A N=27 Pilot of Training on 988 and Narcan
Suicide · Overdose Accidental · Overdose Antidote
Primary: Acceptability of Intervention Measure — 17.74 units on a scale
N/A N=915 Community Health Through Engagement and Environmental Renewal
Family Relations · Blight
Primary: Problem Behaviors in Children Ages 11 to 16 Years. — 0.49; 0.33; 5.67 score on a scale — p=<0.01
N/A N=20 Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down Syndrome
Down Syndrome · Physical Inactivity
Primary: Attendance — 21.7 Number of Classes Attended
Phase 2 N=75 Testing Ramipril to Prevent Memory Loss in People With Glioblastoma
Glioblastoma · Radiotherapy; Complications · Cognitive Decline
Primary: Change From Baseline Neurocognitive Function at 10 Weeks - Hopkins Verbal Learning Test-Revised (HVLT-R) Total Recall Standardized Score — 0.09; -0.40 Change in…